Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

CYP19A1 Gene and Pharmacogenetics of Response

Next Previous
X
Search
Trial Profile

CYP19A1 Gene and Pharmacogenetics of Response

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 07 Aug 2023

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Testosterone cipionate (Primary)
  • Indications Male osteoporosis
  • Focus Pharmacogenomic; Therapeutic Use

    • Most Recent Events

    • 18 Jun 2023 Results (n=105) of a secondary analysis pharmacogenetics of response to T therapy using samples obtained from this trial presented at the 105th Annual Meeting of the Endocrine Society
    • 18 Mar 2021 Data from this study was used for secondary analysis assessing the skeletal response to testosterone therapy in hypogonadal men with T2D compared to hypogonadal men without T2D, published in the Journal of Clinical Endocrinology and Metabolism.
    • 28 Feb 2019 Status changed from active, no longer recruiting to completed.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top